Worsening Diabetes-Related Retinopathy For patients with diabetes, theres a potential risk that GLP-1 drugs could worsen retinopathy, a diabetes-related eye condition
doi:10.1177/15648265080292S111
Versus if you [00:35:00] take a hormone from outside sources, it affects straight to the pituitary
The optimal injection timing can vary between patients, and some find that morning injections versus evening injections make a significant difference in sleep quality
Aon's early analysis reveals: A Bend in the Cost Curve: After the widely reported initial jump in costs related to initiation of GLP-1 medications, cost growth rates diverge from the GLP-1 treatment group, trending at half the rate of a precisely matched control group in the last 12 months of the analysis period
\n\n\n\n Cardiovascular Research: Heart, Vessels, and Vascular Protection \n\n\n\n The cardiovascular system has also been examined in BPC-157 research, with studies focusing on heart tissue protection, blood vessel integrity, and hemodynamic stability